These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study. Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794 [TBL] [Abstract][Full Text] [Related]
24. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine. Auerbach BS; Lake AM; Wilson ME; Willingham FF; Shematek J; Moulton L; Deforest A; Halsey NA Biologicals; 1998 Jun; 26(2):145-53. PubMed ID: 9811522 [TBL] [Abstract][Full Text] [Related]
25. Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine. Podda A; De Luca EC; Contu B; Furlan R; Maida A; Moiraghi A; Stramare D; Titone L; Uxa F; Di Pisa F; Peppoloni S J Pediatr; 1994 Jun; 124(6):921-6. PubMed ID: 8201477 [TBL] [Abstract][Full Text] [Related]
26. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526 [TBL] [Abstract][Full Text] [Related]
27. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis. Wilson TR J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630 [TBL] [Abstract][Full Text] [Related]
28. An overview of the status of acellular pertussis vaccines in practice. Lopez AL; Blumberg DA Drugs; 1997 Aug; 54(2):189-96. PubMed ID: 9257078 [TBL] [Abstract][Full Text] [Related]
29. Duration of pertussis immunity after DTaP immunization: a meta-analysis. McGirr A; Fisman DN Pediatrics; 2015 Feb; 135(2):331-43. PubMed ID: 25560446 [TBL] [Abstract][Full Text] [Related]
30. [The immunological basis of the administration of DTP-polio vaccine]. Cohen H Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905 [TBL] [Abstract][Full Text] [Related]
31. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Olin P; Rasmussen F; Gustafsson L; Hallander HO; Heijbel H Lancet; 1997 Nov; 350(9091):1569-77. PubMed ID: 9393335 [TBL] [Abstract][Full Text] [Related]
32. Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens. Miller E; Ashworth LA; Robinson A; Waight PA; Irons LI Lancet; 1991 Jan; 337(8733):70-3. PubMed ID: 1670725 [TBL] [Abstract][Full Text] [Related]
33. Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study. Englund JA; Decker MD; Edwards KM; Pichichero ME; Steinhoff MC; Anderson EL Pediatrics; 1994 Jan; 93(1):37-43. PubMed ID: 8265321 [TBL] [Abstract][Full Text] [Related]
34. Pertussis: acellular, whole-cell, new vaccines, what to choose? Locht C Expert Rev Vaccines; 2016 Jun; 15(6):671-3. PubMed ID: 26938372 [No Abstract] [Full Text] [Related]
35. Comparison of adverse effects following immunization with vaccine containing whole-cell vs. acellular pertussis components. Zieliński A; Rosińska M Przegl Epidemiol; 2008; 62(3):589-96. PubMed ID: 19108523 [TBL] [Abstract][Full Text] [Related]
36. Persistence of antibodies at 5-6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5-6 years of age. Langue J; Matisse N; Pacoret P; Undreiner F; Boisnard F; Soubeyrand B; Vaccine; 2004 Mar; 22(11-12):1406-14. PubMed ID: 15063563 [TBL] [Abstract][Full Text] [Related]
37. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination. Prelog M; Almanzar G; Rieber N; Ottensmeier B; Zlamy M; Liese J Vaccine; 2013 Jan; 31(2):387-93. PubMed ID: 23142306 [TBL] [Abstract][Full Text] [Related]